Pitolisant (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Pitolisant" in Serbian language version.
refsWebsite
Global rank
Serbian rank
low place
low place
149th place
283rd place
low place
low place
610th place
653rd place
1st place
1st place
doi.org (Global: 2nd place; Serbian: 4th place)
- Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- Celanire S, Wijtmans M, Talaga P, Leurs R, de Esch IJ (2005). „Keynote review: histamine H3 receptor antagonists reach out for the clinic”. Drug Discov. Today. 10 (23–24): 1613—27. PMID 16376822. doi:10.1016/S1359-6446(05)03625-1.
- -{Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, Lecomte JM, Parmentier R, Anaclet C, Lin JS, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, Arrang JM, Ganellin CR, Stark H, Schunack W, Schwartz JC. BF2.649 [13-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. Ligneau, X.; Perrin, D.; Landais, L.; Camelin, J. C.; Calmels, T. P.; Berrebi-Bertrand, I.; Lecomte, J. M.; Parmentier, R.; Anaclet, C.; Lin, J. S.; Bertaina-Anglade, V.; La Rochelle, C. D.; d'Aniello, F.; Rouleau, A.; Gbahou, F.; Arrang, J. M.; Ganellin, C. R.; Stark, H.; Schunack, W.; Schwartz, J. C. (јануар 2007). „BF2.649 1-{3-3-(4-Chlorophenyl)propoxypropyl}piperidine, hydrochloride, a nonimidazole inverse agonist/Antagonist at the human histamine H3 receptor: Preclinical pharmacology”. Journal of Pharmacology and Experimental Therapeutics. 320 (1): 365—75. PMID 17005916. doi:10.1124/jpet.106.111039.
- Lin JS, Dauvilliers Y, Arnulf I, Bastuji H, Anaclet C, Parmentier R, Kocher L, Yanagisawa M, Lehert P, Ligneau X, Perrin D, Robert P, Roux M, Lecomte JM, Schwartz JC (април 2008). „An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients”. Neurobiology of Disease. 30 (1): 74—83. PMID 18295497. doi:10.1016/j.nbd.2007.12.003.
- Ligneau, X.; Landais, L.; Perrin, D.; Piriou, J.; Uguen, M.; Denis, E.; Robert, P.; Parmentier, R.; Anaclet, C.; Lin, J. S.; Burban, A.; Arrang, J. M.; Schwartz, J. C. (април 2007). „Brain histamine and schizophrenia: Potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649.” (PDF). Biochemical Pharmacology. 73 (8): 1215—24. PMID 17343831. doi:10.1016/j.bcp.2007.01.023.
- Stocking EM, Letavic MA (2008). „Histamine H3 antagonists as wake-promoting and pro-cognitive agents”. Current Topics in Medicinal Chemistry. 8 (11): 988—1002. PMID 18673168. doi:10.2174/156802608784936728.
- Schwartz, Jean-Charles (2011). „The histamine H3 receptor: From discovery to clinical trials with pitolisant”. British Journal of Pharmacology. 163 (4): 713—721. PMC 3111674
. PMID 21615387. doi:10.1111/j.1476-5381.2011.01286.x.
elsevier.com (Global: 610th place; Serbian: 653rd place)
linkinghub.elsevier.com
- Celanire S, Wijtmans M, Talaga P, Leurs R, de Esch IJ (2005). „Keynote review: histamine H3 receptor antagonists reach out for the clinic”. Drug Discov. Today. 10 (23–24): 1613—27. PMID 16376822. doi:10.1016/S1359-6446(05)03625-1.
hal.science (Global: low place; Serbian: low place)
inserm.hal.science
- Lin JS, Dauvilliers Y, Arnulf I, Bastuji H, Anaclet C, Parmentier R, Kocher L, Yanagisawa M, Lehert P, Ligneau X, Perrin D, Robert P, Roux M, Lecomte JM, Schwartz JC (април 2008). „An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients”. Neurobiology of Disease. 30 (1): 74—83. PMID 18295497. doi:10.1016/j.nbd.2007.12.003.
- Ligneau, X.; Landais, L.; Perrin, D.; Piriou, J.; Uguen, M.; Denis, E.; Robert, P.; Parmentier, R.; Anaclet, C.; Lin, J. S.; Burban, A.; Arrang, J. M.; Schwartz, J. C. (април 2007). „Brain histamine and schizophrenia: Potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649.” (PDF). Biochemical Pharmacology. 73 (8): 1215—24. PMID 17343831. doi:10.1016/j.bcp.2007.01.023.
nih.gov (Global: 4th place; Serbian: 8th place)
ncbi.nlm.nih.gov
- Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- Celanire S, Wijtmans M, Talaga P, Leurs R, de Esch IJ (2005). „Keynote review: histamine H3 receptor antagonists reach out for the clinic”. Drug Discov. Today. 10 (23–24): 1613—27. PMID 16376822. doi:10.1016/S1359-6446(05)03625-1.
- -{Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, Lecomte JM, Parmentier R, Anaclet C, Lin JS, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, Arrang JM, Ganellin CR, Stark H, Schunack W, Schwartz JC. BF2.649 [13-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. Ligneau, X.; Perrin, D.; Landais, L.; Camelin, J. C.; Calmels, T. P.; Berrebi-Bertrand, I.; Lecomte, J. M.; Parmentier, R.; Anaclet, C.; Lin, J. S.; Bertaina-Anglade, V.; La Rochelle, C. D.; d'Aniello, F.; Rouleau, A.; Gbahou, F.; Arrang, J. M.; Ganellin, C. R.; Stark, H.; Schunack, W.; Schwartz, J. C. (јануар 2007). „BF2.649 1-{3-3-(4-Chlorophenyl)propoxypropyl}piperidine, hydrochloride, a nonimidazole inverse agonist/Antagonist at the human histamine H3 receptor: Preclinical pharmacology”. Journal of Pharmacology and Experimental Therapeutics. 320 (1): 365—75. PMID 17005916. doi:10.1124/jpet.106.111039.
- Lin JS, Dauvilliers Y, Arnulf I, Bastuji H, Anaclet C, Parmentier R, Kocher L, Yanagisawa M, Lehert P, Ligneau X, Perrin D, Robert P, Roux M, Lecomte JM, Schwartz JC (април 2008). „An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients”. Neurobiology of Disease. 30 (1): 74—83. PMID 18295497. doi:10.1016/j.nbd.2007.12.003.
- Ligneau, X.; Landais, L.; Perrin, D.; Piriou, J.; Uguen, M.; Denis, E.; Robert, P.; Parmentier, R.; Anaclet, C.; Lin, J. S.; Burban, A.; Arrang, J. M.; Schwartz, J. C. (април 2007). „Brain histamine and schizophrenia: Potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649.” (PDF). Biochemical Pharmacology. 73 (8): 1215—24. PMID 17343831. doi:10.1016/j.bcp.2007.01.023.
- Stocking EM, Letavic MA (2008). „Histamine H3 antagonists as wake-promoting and pro-cognitive agents”. Current Topics in Medicinal Chemistry. 8 (11): 988—1002. PMID 18673168. doi:10.2174/156802608784936728.
- Schwartz, Jean-Charles (2011). „The histamine H3 receptor: From discovery to clinical trials with pitolisant”. British Journal of Pharmacology. 163 (4): 713—721. PMC 3111674 . PMID 21615387. doi:10.1111/j.1476-5381.2011.01286.x.
prous.com (Global: low place; Serbian: low place)
- „Prous Science: Molecule of the Month September 2011”. „Архивирана копија”. Архивирано из оригинала 26. 09. 2011. г. Приступљено 19. 07. 2012.
sciencedirect.com (Global: 149th place; Serbian: 283rd place)
- Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
web.archive.org (Global: 1st place; Serbian: 1st place)
- „Prous Science: Molecule of the Month September 2011”. „Архивирана копија”. Архивирано из оригинала 26. 09. 2011. г. Приступљено 19. 07. 2012.
wikipedia.org (Global: low place; Serbian: low place)
sr.wikipedia.org
- Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.